珀金埃尔默网站上的Cookie
珀金埃尔默使用cookies来确保我们为您提供在我们网站上的最佳体验。 这可能包括来自第三方网站的cookies。 如果您不改变您的设置点击继续,我们会认为您同意接收本网站的cookies。 您可以随时更改您的Cookie设置。 要了解更多信息,请查看我们的Cookie政策,其中包含有关如何管理Cookie的信息。

Fighting Bubble Boy Disease

March 26, 2015

Fighting Bubble Boy Disease

There is a famous photo of a young David Vetter staring out from inside his sterile plastic bubble in 1983. His piercing, dark eyes and haunting look tug at your heartstrings. Dubbed “bubble boy” by the media, David suffered from Severe Combined Immunodeficiency, or SCID, disease. Not long after the photo, David died from lymphoma.

SCID affects 1 in every 50,000 to 100,000 births. It is a primary immunodeficiency disorder leaving infants with few or no T lymphocytes that help resist infections. Several different genetic defects cause SCID. Untreated, SCID is usually fatal. If detected within the first few weeks of life, however, cord blood or bone marrow transplants can treat and even cure the disease.

More than 30 years after “Bubble Boy’s” passing, children with SCID and their families now have reason to hope. In both the United States and Canada, PerkinElmer has received authorization to offer its newborn screening kit for SCID to healthcare professionals throughout the two countries. With these recent approvals, PerkinElmer’s VICTOR™ EnLite™ and EnLite™ Neonatal TREC kit is now providing SCID screening in more than 30 countries around the world.

EnLite Neonatal TREC brochure – (outside US and Canada)

EnLite Neonatal TREC brochure – (US and Canada only)


更多故事关于 诊断, 新生儿筛查, Innovation Spotlight

Related Products